Difference between revisions of "I-123 Biomarker Committee"
Jump to navigation
Jump to search
m |
|||
| Line 8: | Line 8: | ||
==Recent Meetings/Call Summaries== | ==Recent Meetings/Call Summaries== | ||
| − | *[[Media: | + | *[[Media:2018_08-17_QIBA_SPECT_I-123_Call Summary-FINAL.pdf | August 17, 2018]] |
| − | |||
| − | |||
==Profile Development== | ==Profile Development== | ||
Revision as of 19:07, 9 August 2018
- Co-chairs: John Dickson, PhD; John Seibyl, MD
- Secretary: Julie Lisiecki
Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases